Clinical Trial Update: A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy [Phase 4]

View source ↗

Summary

A Phase 4, non-randomized, open-label study assessing the effect and safety of the ILUVIEN fluocinolone acetonide intravitreal implant in chronic diabetic macul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• ILUVIEN (fluocinolone acetonide)

Snippet

Sponsor: Alimera Sciences | Conditions: Chronic Diabetic Macular Edema | Phase 4 | Status: COMPLETED | Results posted: 2015-09-16